apl. Prof. Dr. Antoniu-Oreste Gostian

Medizinische Fakultät Department of Otorhinolaryngology – Head and Neck Surgery

EAONO/JOS classification for acquired cholesteatoma: evaluating the impact of the number of affected sites on treatment and outcomes (2023) Renner B, de Vasconcelos Craveiro A, Balk M, Allner M, Sievert M, Müller SK, Mantsopoulos K, et al. Journal article The influence of obstructive sleep apnea and continuous positive airway pressure on the nasal microbiome (2023) Lenk C, Meßbacher ME, Abel J, Müller SK, Mantsopoulos K, Gostian AO, Sievert M, et al. Journal article Cellular density and variability in laryngeal and pharyngeal squamous cell carcinoma using confocal laser endomicroscopy (2023) Sievert M, Aubreville M, Eckstein M, Mantsopoulos K, Koch M, Gostian AO, Müller SK, et al. Journal article The Effects of a “New Generation” of Heat and Moisture Exchangers in Laryngectomized Patients with Previous Heat and Moisture Changer Experience (2023) Almajali O, Balk M, Rupp R, Allner M, Sievert M, Iro H, Schützenberger A, Gostian AO Journal article The modified Polsby–Popper score, a novel quantitative histomorphological biomarker and its potential to predict lymph node positivity and cancer-specific survival in oral tongue squamous cell carcinoma (2023) Csűry TD, Csűry AZ, Balk M, Kist A, Rupp R, Müller SK, Sievert M, et al. Journal article Synthetic mucus for an ex vivo phonation setup: Creation, application, and effect on excised porcine larynges (2022) Peters G, Jakubaß B, Weidenfeller K, Kniesburges S, Böhringer D, Wendler O, Müller SK, et al. Journal article Additional Diffusion-Weighted Imaging with Background Body Signal Suppression (DWIBS) Improves Pre-Therapeutical Detection of Early-Stage (pT1a) Glottic Cancer: A Feasibility and Interobserver Reliability Study (2022) Schleder S, May M, Habicher W, Dinkel J, Schreyer AG, Gostian AO, Schicho A Journal article Updated analysis of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma with induction chemoimmunotherapy followed by radioimmunotherapy (2022) Hecht M, Eckstein M, Kallies A, Von Der Grun J, Illmer T, Klautke G, Laban S, et al. Conference contribution Exosomal serum biomarkers as predictors for laryngeal carcinoma (2022) Müller SK, Schuster J, Wendler O, Iro H, Gostian AO Conference contribution Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP) (2022) Balk M, Rupp R, Mantsopoulos K, Allner M, Grundtner P, Müller SK, Traxdorf M, et al. Conference contribution